Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Tertiary Lymphoid Structures × tazemetostat × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Lymphoma, Follicular 2 Urinary Bladder Neoplasms 1 Tertiary Lymphoid Structures 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

tazemetostat 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04705818 2026-03-06

CAIRE

Institut Bergonié

Phase 2 Completed

GastrointestinalSarcoma

Tertiary Lymphoid Structures, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡